Science
Seres Therapeutics Inc (NASDAQ: MCRB) Has Decreased By -28.58 Percent This Year. Is It A Better Buy Than Others?
Seres Therapeutics Inc (NASDAQ:MCRB)’s traded shares stood at 0.11 million during the last session, with the company’s beta value hitting 2.88. At the close of
